OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Management of atopic dermatitis: a narrative review
Michelle Goh, Jenny Sung Won Yun, John Su
The Medical Journal of Australia (2022) Vol. 216, Iss. 11, pp. 587-593
Closed Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Neutrophil recruitment by CD4 tissue-resident memory T cells induces chronic recurrent inflammation in atopic dermatitis
Chunjiao Zheng, Ting Cao, Chengbin Ye, et al.
Clinical Immunology (2023) Vol. 256, pp. 109805-109805
Closed Access | Times Cited: 14

Advances in skin gene therapy: utilizing innovative dressing scaffolds for wound healing, a comprehensive review
Fatemeh Karimzadeh, Elahe Soltani Fard, Akram Nadi, et al.
Journal of Materials Chemistry B (2024) Vol. 12, Iss. 25, pp. 6033-6062
Closed Access | Times Cited: 5

Identification of a dual JAK3/TEC family kinase inhibitor for atopic dermatitis therapy
Y.C. Du, Longling Wang, Jingmei Zhou, et al.
Biochemical Pharmacology (2025) Vol. 232, pp. 116740-116740
Closed Access

Tapinarof cream 1% once daily was well tolerated in adults and children with atopic dermatitis in two phase 3 randomized trials
Linda Stein Gold, J.Q. Del Rosso, Benjamin D. Ehst, et al.
Journal of Dermatological Treatment (2025) Vol. 36, Iss. 1
Open Access

The Origin, Intricate Nature, and Role of the Skin Surface pH (pHSS) in Barrier Integrity, Eczema, and Psoriasis
Dalibor Mijaljica, Joshua P. Townley, Daniel J. Klionsky, et al.
Cosmetics (2025) Vol. 12, Iss. 1, pp. 24-24
Open Access

Costunolide nanosuspension loaded in dissolvable microneedle arrays for atopic dermatitis treatment
Xulong Xue, Pengcheng Zhang, Yang Cao, et al.
International Journal of Pharmaceutics (2025), pp. 125566-125566
Closed Access

LIGHT signaling through LTβR and HVEM in keratinocytes promotes psoriasis and atopic dermatitis-like skin inflammation
Rinkesh Kumar Gupta, Daniela Salgado Figueroa, Kai Fung, et al.
Journal of Autoimmunity (2024) Vol. 144, pp. 103177-103177
Closed Access | Times Cited: 4

IL-22 in Atopic Dermatitis
Julia Laska, Maciej Tota, Julia Łacwik, et al.
Cells (2024) Vol. 13, Iss. 16, pp. 1398-1398
Open Access | Times Cited: 4

Type 2 Inflammation and Its Role in Dermatologic Diseases
Raj Chovatiya, Jason E. Hawkes, Douglas DiRuggiero, et al.
International Journal of Dermatology (2025)
Open Access

Yu-Ping-Feng-San alleviates inflammation in atopic dermatitis mice by TLR4/MyD88/NF-κB pathway
Jing Nie, Xiaoyuan Jiang, Guomi Wang, et al.
Journal of Ethnopharmacology (2024) Vol. 329, pp. 118092-118092
Closed Access | Times Cited: 3

Atopic Dermatitis: Clinical Aspects and Treatments
Ryan S.Q. Geng, R. Gary Sibbald
Advances in Skin & Wound Care (2024) Vol. 37, Iss. 7, pp. 346-352
Closed Access | Times Cited: 3

Bilateral Association Between Atopic Dermatitis® and Alopecia Areata: A Systematic Review and Meta-Analysis
Rong Sun, Deqi Kong
Dermatitis (2023) Vol. 35, Iss. 3, pp. 208-218
Closed Access | Times Cited: 7

Monotropein mitigates atopic dermatitis-like skin inflammation through JAK/STAT signaling pathway inhibition
In‐Young Yang, Na-Hee Jeong, Young‐Ae Choi, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116911-116911
Open Access | Times Cited: 2

Burden of Disease and Unmet Needs in the Diagnosis and Management of Atopic Dermatitis in Diverse Skin Types in Australia
Ashling Courtney, Diego J. Lopez, Adrian J. Lowe, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 11, pp. 3812-3812
Open Access | Times Cited: 6

The Application of Dupilumab to Pediatric Patients Aged 6–11yrs with Moderate-to-Severe Atopic Dermatitis Whose Disease is Not Adequately Controlled: The Clinical Data so Far
Sarah Balboul, Julia Kahn, Alexis Tracy, et al.
Drug Design Development and Therapy (2023) Vol. Volume 17, pp. 1323-1327
Open Access | Times Cited: 5

Diagnosis, assessment and management of atopic dermatitis in children with skin of colour
Christian Gan, Roland Brand, Rachael Foster, et al.
Australian Journal of General Practice (2023) Vol. 52, Iss. 10
Open Access | Times Cited: 4

Anti-Atopic Dermatitis Effect of TPS240, a Novel Therapeutic Peptide, via Suppression of NF-κB and STAT3 Activation
Dongwoo Lee, Jeon Hwang‐Bo, Karpagam Veerappan, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15814-15814
Open Access | Times Cited: 4

Topical application of Artemisia annua L. essential oil ameliorates 2,4-dintrochlorobenzene-induced atopic dermatitis in mice
Zhian Huang, Bin Fan, Weiwei Mao, et al.
Journal of Ethnopharmacology (2024) Vol. 333, pp. 118439-118439
Closed Access | Times Cited: 1

Dupilumab for treatment of severe atopic dermatitis accompanied by lichenoid amyloidosis in adults: Two case reports
Xueqi Zhao, Wen-Jing Zhu, Yan Mou, et al.
World Journal of Clinical Cases (2023) Vol. 11, Iss. 10, pp. 2301-2307
Open Access | Times Cited: 3

A Retrospective Analysis of Risk Factors for Atopic Dermatitis Severity
Min Luo, Huichun Su, Jinger Lin, et al.
Dermatitis (2023) Vol. 35, Iss. S1, pp. S81-S90
Closed Access | Times Cited: 2

Peculiarities of treatment of dermatitis in young children
Н. М. Шарова, С. В. Кукало
Meditsinskiy sovet = Medical Council (2024), Iss. 1, pp. 206-210
Open Access

Page 1 - Next Page

Scroll to top